BioNTech SE (BNTX)
108.44
+3.01 +2.85%
NASDAQ
Jan 22, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 186.40M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.997 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -466.24M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 89.86% |
| Profit Margin (Quarterly) | -311.4% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 26.11B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 133.84 |
| PE Ratio | -- |
| Price to Book Value | 23.97 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.1893 |
| Free Cash Flow (Quarterly) | -255.45M |
| Return on Equity | Upgrade |
View All BNTX News
News
-
WireHeadlineTime (ET)
-
Yahoo01/23 14:25
-
Yahoo01/23 10:30
-
Yahoo01/23 06:44
-
Yahoo01/23 06:04
-
SA Breaking News01/22 22:01
-
Yahoo01/22 16:08
-
Yahoo01/22 14:55
-
SA Breaking News01/22 14:05
-
MT Newswires01/22 12:52
-
Yahoo01/22 12:15
-
Globe Newswire01/22 12:00
-
MT Newswires01/22 11:15
-
Yahoo01/22 09:36
-
PR Newswire01/22 09:31
-
Yahoo01/22 08:06
-
Yahoo01/22 08:00
-
SA Breaking News01/22 07:20
-
Yahoo01/22 07:00
-
MT Newswires01/22 05:18
-
SA Breaking News01/22 04:20
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 03/31/2021 | Earnings | BioNTech SE Fourth Quarter Earnings Results for 2020 |
| 03/31/2021 | Misc | BioNTech SE Fourth Quarter Earnings Conference Call for 2020 |
| 11/10/2020 | Earnings | BioNTech SE Third Quarter Earnings for 2020 Release |
| 11/10/2020 | Misc | BioNTech SE Third Quarter Earnings Conference Call for 2020 |
| 08/11/2020 | Earnings | BioNTech SE Second Quarter Earnings for 2020 Release |
| 08/11/2020 | Misc | BioNTech SE Second Quarter Earnings Conference Call for 2020 |
| 06/26/2020 10:00 CEST | Misc | BioNTech SE Annual General Meeting for 2019 |
| 05/12/2020 | Earnings | BioNTech SE First Quarter Earnings for 2020 Release |
| 05/12/2020 | Misc | BioNTech SE First Quarter Earnings Conference Call for 2020 |
| 03/31/2020 | Earnings | BioNTech SE Fourth Quarter Earnings for 2019 Release |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.biontech.de
- Investor Relations URL: N/A
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: N/A
- Next Earnings Release: Mar. 31, 2021
- Last Earnings Release: Nov. 10, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: BioNTech SE is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 108.44 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| GERM | ETFMG Treatments Testing and Adv ETF | 4.47% |
| BBH | VanEck Vectors Biotech ETF | 3.14% |
| IDNA | iShares Genomics Immnlgy & Hlthcr ETF | 3.11% |
| BIOABX | AAM Biotechnology Opps 2020-2 RE | 2.91% |
| F0000162BO | AAM Biotechnology Opp 15M CDA 2020-4 FCA | 2.78% |
| ZDEU | SPDR® Solactive Germany ETF | 1.85% |
| FEVR | Inspire Faithward Large Cp Mmntm ESG ETF | 1.56% |
| AIIQ | AI Powered International Equity ETF | 1.47% |
| LHCQX | Lord Abbett Health Care R3 | 1.23% |
| POAGX | PRIMECAP Odyssey Aggressive Growth | 1.23% |
| BFGFX | Baron Focused Growth Retail | 0.86% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- BNTX Tweets Stocktwits
Advertisement
